Corona, CA — June 17, 2003 — Watson Pharmaceuticals has named Ian McInnes to the position of executive vice president for supply chain, with responsibility for manufacturing operations, quality assurance and quality control for Watson's business.
Headquartered in Corona, Calif., Watson is a specialty pharmaceutical company producing both branded and generic pharmaceutical products. Founded in 1984, Watson now has approximately 3,700 employees worldwide, eight manufacturing facilities and 2002 revenue of more than $1.2 billion.
McInnes will report to Joseph Papa, Watson's president and chief operating officer. The company's quality compliance function will continue to report to Watson's chairman and CEO, Allen Chao.
Commenting on McInnes' appointment, Papa, who previously worked with the new EVP, said, "His background and past success in managing supply chain pharmaceutical production operations will be particularly advantageous to Watson as we progress with our long-term strategic plan for growth."
McInnes, who holds a Ph.D. in manufacturing technology and manufacturing management from the University of Strathclyde, Scotland, brings to Watson strategic and operational experience accrued in a variety of functions at different large pharmaceutical and healthcare organizations. His responsibilities have ranged from manufacturing, quality assurance and engineering to environmental health and safety, procurement, supply chain management, strategic development and new product introductions.
He joins Watson following a position as senior vice president for global supply and corporate officer, head of global supply for Pharmacia Corporation. While at Pharmacia, he had direct accountability for 44 manufacturing facilities in 22 countries with an annual production value of $3.1 billion.
Prior industry experience included positions for various Glaxo Wellcome affiliates, Baxter Healthcare, CR Bard, Baxter Travenol and ICI Pharmaceuticals.
McInnes is a chartered engineer with the Institute of Electrical Engineers (M.I.E.E.).